Skip to main content

1 Result(s)

within Dirk Arnold Remove this filter Medicine & Public Health Remove this filter Biomedicine, general Remove this filter

and

  1. No Access

    Article

    Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy

    The aim of this post hoc analysis of the VELOUR study (ClinicalTrials.gov NCT00561470) was to investigate the treatment effect of adding aflibercept to second-line infusional 5-fluorouracil (5-FU), leucovorin ...

    Eric Van Cutsem, Florence Joulain, Paulo M. Hoff, Edith Mitchell… in Targeted Oncology (2016)